| Stage | ATI | % of rev | CCL | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.4B | 100.00% | $8.4B | 100.00% | CCL ×5.92 |
| Gross profit | $380M | 26.71% | $7.8B | 92.71% | CCL +66.0pp |
| Operating income | $272M | 19.10% | $2.2B | 26.32% | CCL +7.2pp |
| Pre-tax income | $245M | 17.19% | $1.9B | 22.99% | CCL +5.8pp |
| Net income | $193M | 13.58% | $1.9B | 22.80% | CCL +9.2pp |
| Stage | ATI | CCL | Gap · A − B |
|---|---|---|---|
| Revenue | $1.4B100.00% | $8.4B100.00% | CCL ×5.92 |
| Gross profit | 26.71%$380M | 92.71%$7.8B | CCL +66.0pp |
| Operating income | 19.10%$272M | 26.32%$2.2B | CCL +7.2pp |
| Pre-tax income | 17.19%$245M | 22.99%$1.9B | CCL +5.8pp |
| Net income |
| 13.58%$193M |
| 22.80%$1.9B |
| CCL +9.2pp |
No shared counterparties.